Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neglected nephropathy.

Tuck Y Yong1, Patrick J Phillips, P Toby H Coates

  • 1Department of Endocrinology, The Queen Elizabeth Hospital, South Australia.

Australian Family Physician
|June 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal concentrations of Quaternary ammonium compounds in wastewater treatment effluents during the COVID-19 pandemic, 2020-2021.

Chemosphere·2024
Same author

Environmental and anthropogenic drivers of contaminants in agricultural watersheds with implications for land management.

The Science of the total environment·2021
Same author

A comparison of the inflammatory response following autologous compared with allogenic islet cell transplantation.

Annals of translational medicine·2021
Same author

Groundwater discharges as a source of phytoestrogens and other agriculturally derived contaminants to streams.

The Science of the total environment·2020
Same author

Pesticides and their degradates in groundwater reflect past use and current management strategies, Long Island, New York, USA.

The Science of the total environment·2020
Same author

Spatiotemporal variation in occurrence and co-occurrence of pesticides, hormones, and other organic contaminants in rivers in the Chesapeake Bay Watershed, United States.

The Science of the total environment·2020
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Diabetic nephropathy management focuses on slowing disease progression through monitoring and early intervention. Key therapies include ACE inhibitors and ARBs for hypertension and albuminuria, with nephrologist referral for renal insufficiency.

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Background:

  • Diabetic nephropathy significantly impacts morbidity, mortality, and healthcare costs in diabetic patients.
  • Understanding the disease progression allows for potential intervention to alter its natural course.

Purpose of the Study:

  • To examine the natural history of diabetic nephropathy.
  • To provide guidelines for detection, management, and future treatment of diabetic nephropathy.
  • To highlight the importance of prevention and slowing disease progression.

Main Methods:

  • Review of the natural history of diabetic nephropathy.
  • Guidelines for monitoring renal function and risk factors.
  • Analysis of therapeutic interventions, including ACE inhibitors and ARBs.

Related Experiment Videos

  • Criteria for referral to a nephrologist.

    • Main Results:

    • Early, active intervention is crucial for managing diabetic nephropathy.
    • Angiotensin-converting enzyme inhibitors and receptor antagonists are vital for controlling hypertension and reducing albuminuria.
    • Intensive risk factor management can significantly reduce cardiovascular events and progression to macroalbuminuria.
    • Referral to a nephrologist is recommended for patients with renal insufficiency (creatinine clearance >30 mL/minute).

    Conclusions:

    • Prevention and slowing progression are paramount in diabetic nephropathy management.
    • Monitoring renal function and risk factors enables early intervention.
    • Pharmacological therapies targeting hypertension and albuminuria are essential.
    • Timely specialist referral improves outcomes for patients with advanced renal impairment.